Register Now for Webinar on Mpox: Where Are We Now?

Presenter: Jason E. Zucker, MD
Columbia University
Moderator: Judith S. Currier, MD
University of California Los Angeles
February 29, 2024, at 10:00 AM – 11:15 AM PT

Mpox illnesses, including severe infections, continue to occur across the United States and around the world. According to the Centers for Disease Control and Prevention, people with HIV-associated immunosuppression and people with HIV who are not virologically suppressed can be at increased risk of severe mpox. This webinar will provide an update on what clinicians need to know regarding mpox, particularly the latest guidance in clinical recognition, management, and treatment, including current and ongoing research and gaps in knowledge.

Learning Objectives

On completion of this activity, learners will be able to:

  • Explain what we knew about mpox before the 2022 mpox outbreak
  • Describe what we learned about testing, treatment, and vaccination during the 2022 mpox outbreak and what we are learning from the active outbreak in the Democratic Republic of the Congo
  • Summarize what is still unknown and describe how ongoing research initiatives, like the STOMP study, contribute to addressing these knowledge gaps

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.